<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/static/PubMed.dtd">
<ArticleSet><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>17</Volume><Issue>2</Issue><PubDate PubStatus="epublish"><Year>2012</Year><Month>02</Month><Day>15</Day></PubDate></Journal><ArticleTitle>Serologic celiac disease in patients with inflammatory bowel disease</ArticleTitle><FirstPage>6555</FirstPage><LastPage>6555</LastPage><Language>EN</Language><AuthorList><Author><FirstName>Hamid</FirstName><LastName>Tavakkoli</LastName><Affiliation>Department of Gastroenterology, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. h_tavakoli@med.mui.ac.ir</Affiliation></Author><Author><FirstName>Saeid</FirstName><LastName>Haghdani</LastName></Author><Author><FirstName>Haiedeh</FirstName><LastName>Adilipour</LastName></Author><Author><FirstName>Hamed</FirstName><LastName>Daghaghzadeh</LastName></Author><Author><FirstName>Mohammad</FirstName><LastName>Minakari</LastName></Author><Author><FirstName>Peyman</FirstName><LastName>Adibi</LastName></Author><Author><FirstName>Khalil</FirstName><LastName>Ahmadi</LastName></Author><Author><FirstName>Mohammah Hassan</FirstName><LastName>Emami</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2011</Year><Month>01</Month><Day>10</Day></PubDate><PubDate PubStatus="accepted"><Year>2011</Year><Month>06</Month><Day>21</Day></PubDate><PubDate PubStatus="revised"><Year>2011</Year><Month>12</Month><Day>23</Day></PubDate></History><Abstract>BACKGROUND: There is an association&amp;nbsp; of celiac disease (CD) with several gastrointestinal illnesses. We aimed to determine&amp;nbsp; the prevalence of CD in patients with inflammatory bowel disease (IBD) to evaluate the value of the routine serological tests for CD in these patients. METHODS: patients with IBD underwent&amp;nbsp; screening test for CD. The screening test was based on IgA anti-tTG antibody evaluated by ELISA method and IgA EMA (endomysial antibody) measured by the indirect immunofluorescence method. Fisher exact and chi-square and t tests were used for data analysis. RESULTS: the study was conducted on 100 patients, with a mean age of 34.74 &amp;plusmn; 12.03 (SD) years. The mean simplified Crohn&amp;rsquo;s disease activity index was 90 &amp;plusmn; 17 (SE) and the mean colitis activity index was 3.46&amp;plusmn; 0.96 (SE). Seventeen patients (17%) had IgA anti-tTG antibody levels above the cutoff point (&amp;gt; 20). Thirty-two patients were positive for IgA EMA. IgA EMA was positive in nine IgA anti-tTG positive patients (three patients with Crohn&amp;rsquo;s Disease and six ones with ulcerative colitis). Then, the prevalence of serologic CD was 9% that was higher than that of general population. A significant correlation was found between the results of IgA EMA and those of IgA anti-tTG (p = 0.001) whereas Fisher exact test revealed significant difference between frequency distribution&amp;nbsp; of positive and negative results of IgA EMA and IgA anti-tTG in patients with ulcerative colitis and Crohn&amp;rsquo;s disease (p &amp;lt; 0.001).&amp;nbsp;CONCLUSIONS: the prevalence of serologic CD in general population in Iran has been reported to be 0.6&amp;ndash;0.96%. Then, its prevalence in our sample size was about ten times more than that in general population.KEYWORDS: Celiac Disease, Inflammatory Bowel Disease</Abstract></Article></ArticleSet>
